Novartis AG vs SoFi Technologies Inc — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while SoFi Technologies Inc trades at $17.62 (market cap $21.82B). The key difference: Novartis AG is far larger — about 13.3× SoFi Technologies Inc's market cap, and Novartis AG pays a 3.17% dividend while SoFi Technologies Inc pays none. Which is the better fit depends on your goals.
| NVS | SOFI | |
|---|---|---|
Market Cap | $290.25B | $21.82B |
Sector | Health | Financials |
52-Week High | $168.62 | $32.21 |
52-Week Low | $113.50 | $15.15 |
Enterprise Value | $330.27B | — |
Dividend Yield | 3.17% | — |
Trailing returns across standard periods
Latest headlines on both assets
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →SoFi is a financial services company that was founded in 2011 and is currently based in San Francisco. Initially known for its student loan refinancing business, the company has expanded its product offerings to include personal loans, credit cards, mortgages, investment accounts, banking services, and financial planning. The company intends to be a one-stop shop for its clients' finances and operates solely through its mobile app and website. Through its acquisition of Galileo in 2020 the company also offers payment and account services for debit cards and digital banking.
Read more on SOFI →